Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 16, 2015 - Issue 7
Submit an article Journal homepage
508
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Current lipid-modifying agents

Aris P AgouridisUniversity of Ioannina, Medical School, Department of Internal Medicine, 45110 Ioannina, Greece;Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free London Foundation Trust, Pond Street, London, NW3 2QG, UK+44 20 7830 2258; +44 20 7830 2235; [email protected]
(Honorary Clinical Research Fellow) ,
Theodosios D FilippatosUniversity of Ioannina, Medical School, Department of Internal Medicine, 45110 Ioannina, Greece
&
Niki KatsikiAristotle University of Thessaloniki, Hippokration Hospital, Second Propedeutic Department of Internal Medicine, Medical School, Thessaloniki, Greece
Pages 1117-1118 | Published online: 06 Apr 2015

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

T. D. Filippatos, M. Florentin, M. Georgoula & M. S. Elisaf. (2017) Pharmacological management of diabetic dyslipidemia. Expert Review of Clinical Pharmacology 10:2, pages 187-200.
Read now
Anastazia A. Kei, Theodosios D. Filippatos & Moses S. Elisaf. (2016) The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia. Expert Opinion on Drug Safety 15:4, pages 559-569.
Read now

Articles from other publishers (2)

Sheng-Na Han, Wei-Hong Yang, Jian-Jian Yin, Hai-Long Tao & Li-Rong Zhang. (2019) Drug Treatment of Hyperlipidemia in Chinese Patients: Focus on the Use of Simvastatin and Ezetimibe Alone and in Combination. American Journal of Cardiovascular Drugs 19:3, pages 237-247.
Crossref
N. Papanas & E. Maltezos. (2015) Rosuvastatin and Mean Platelet Volume in Diabetes. Angiology 67:2, pages 113-115.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.